- Home
- ISOU vs DCTH Comparison
ISOU vs DCTH Comparison
Compare ISOU & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISOU
- DCTH
- Stock Information
- Founded
- ISOU 2016
- DCTH 1988
- Country
- ISOU Canada
- DCTH United States
- Employees
- ISOU N/A
- DCTH N/A
- Industry
- ISOU
- DCTH Medical/Dental Instruments
- Sector
- ISOU
- DCTH Health Care
- Exchange
- ISOU Nasdaq
- DCTH Nasdaq
- Market Cap
- ISOU 391.8M
- DCTH 388.3M
- IPO Year
- ISOU N/A
- DCTH N/A
- Fundamental
- Price
- ISOU $8.24
- DCTH $11.65
- Analyst Decision
- ISOU
- DCTH Strong Buy
- Analyst Count
- ISOU 0
- DCTH 4
- Target Price
- ISOU N/A
- DCTH $24.50
- AVG Volume (30 Days)
- ISOU 73.8K
- DCTH 565.2K
- Earning Date
- ISOU 08-01-2025
- DCTH 08-06-2025
- Dividend Yield
- ISOU N/A
- DCTH N/A
- EPS Growth
- ISOU N/A
- DCTH N/A
- EPS
- ISOU N/A
- DCTH 0.06
- Revenue
- ISOU N/A
- DCTH $70,240,000.00
- Revenue This Year
- ISOU N/A
- DCTH $159.22
- Revenue Next Year
- ISOU N/A
- DCTH $41.22
- P/E Ratio
- ISOU N/A
- DCTH $208.23
- Revenue Growth
- ISOU N/A
- DCTH 491.35
- 52 Week Low
- ISOU $5.72
- DCTH $8.08
- 52 Week High
- ISOU $8.72
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- ISOU 61.35
- DCTH 58.67
- Support Level
- ISOU $7.79
- DCTH $10.81
- Resistance Level
- ISOU $8.72
- DCTH $11.32
- Average True Range (ATR)
- ISOU 0.43
- DCTH 0.46
- MACD
- ISOU 0.06
- DCTH 0.14
- Stochastic Oscillator
- ISOU 73.63
- DCTH 85.03
About ISOU IsoEnergy Ltd. Common Shares
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.